Results 71 to 80 of about 8,378 (86)
Some of the next articles are maybe not open access.
Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study.
Urology, 2005 M. Taplin, D. George, S. Halabi, B. Sanford, P. Febbo, K. Hennessy, C. G. Mihos, N. Vogelzang, E. Small, P. Kantoff +9 moresemanticscholar +1 more sourceRandomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.
Journal of Clinical Oncology, 2002 E. Small, S. Halabi, M. Ratain, G. Rosner, W. Stadler, D. Palchak, E. Marshall, R. Rago, V. Hárs, G. Wilding, D. Petrylak, N. Vogelzang +11 moresemanticscholar +1 more source